Open AccessPembrolizumab Versus Chemo in Advanced Esophageal Cancer
Author(s) -
Mark L. Fuerst
Publication year - 2019
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000554328.74089.ad
Subject(s) - medicine , docetaxel , pembrolizumab , irinotecan , chemotherapy , oncology , esophageal cancer , cancer , esophagus , adenocarcinoma , ramucirumab , gastroenterology , colorectal cancer , immunotherapy